Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:developedBy |
antibody therapies
|
| gptkbp:focusesOn |
immuno-oncology
|
| gptkbp:foundedIn |
2014
|
| gptkbp:founder |
gptkb:Roberto_Solari
gptkb:Luc_Dochez |
| gptkbp:headquartersLocation |
gptkb:Stevenage,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tusk Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
CD25-targeting antibody
|
| gptkbp:website |
https://www.tusktherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Luc_Dochez
|
| gptkbp:bfsLayer |
7
|